[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334317-105":59,"doc-detail-334317-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","global-regional-and-national-lifetime-risk-of-developing-and-dying-from-lung-cancer-in-2022-a-population-based-study-in-185-countries","Global, regional, and national lifetime risk of developing and dying from lung cancer in 2022 - A population-based study in 185 countries","","Lifetime cancer risk reflects the cumulative probability of developing cancer at some point in life. Comparative evidence for both the probability of developing lung cancer and dying from it across global, regional, and national populations remains limited. This study derives lung cancer data for 185 countries from GLOBOCAN 2022 and death data from the United Nations. Lifetime risks are estimated using the adjustment for multiple primary cancers approach and compared by region and Human Development Index.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-regional-and-national-lifetime-risk-of-developing-and-dying-from-lung-cancer-in-2022-a-population-based-study-in-185-countries/334317/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-regional-and-national-lifetime-risk-of-developing-and-dying-from-lung-cancer-in-2022-a-population-based-study-in-185-countries/334317.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does “lifetime cancer risk” mean in this study?","Question",{"text":112,"@type":113},"It represents the cumulative probability that a person will be diagnosed with cancer at some age during their lifetime, while considering mortality from other causes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were lifetime risks of lung cancer developing and death estimated?",{"text":117,"@type":113},"Lung cancer data came from GLOBOCAN 2022 and death data from the United Nations. The study estimated lifetime risks using the adjustment for multiple primary cancers (AMP) method.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the global lifetime risks in 2022?",{"text":121,"@type":113},"In 2022, the global lifetime risk of developing lung cancer was 3.49% and the lifetime risk of dying from lung cancer was 2.69%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334317,1790118965,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Global, regional, and national lifetime risk of developing and dying from lung cancer in 2022: A population-based study in 185 countries  \nMeng Li1, Xin Wen1, Xin Liang2, Mengwen Liu1, Li Zhang1, Rongshou Zheng3  \n1Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;  \n2Medical Statistics Office, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;  \n3National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.  \nAbstract  \nBackground: Lifetime cancer risk is an index that indicates the cumulative probability of cancer at some age during a person’s lifetime. Nevertheless, comparative evaluations regarding the probability of developing lung cancer and dying from the disease among diverse populations at the global, regional, and national levels are scarce.  \nMethods: Lung cancer data from 185 countries were obtained from GLOBOCAN 2022, and data on any other cause of death were acquired from the United Nations. The lifetime risks of lung cancer development and death were estimated using adjustment for multiple primary cancers (AMP) method. The lung cancer risks in countries or regions worldwide were compared by region and the Human Development Index (HDI) .  \nResults: The global lifetime risk of developing and dying from lung cancer in 2022 was 3.49% and 2.69%, respectively. The lifetime probabilities of developing lung cancer in countries/areas with low, medium, high, and very high HDIs were 0.33%, 0.95%, 4.72%, and 5.29%, and dying from lung cancer in low, medium, high and very high HDI countries were 0.30%, 0.86%, 3.69% and 3.92%, respectively. After the age of 40 years, the remaining probability of lung cancer development and death decreased with age, leaving a residual risk of 2.00% and 1.71%, respectively, starting at 70 years.  \nConclusions: The probability of developing lung cancer during one’s lifetime is equivalent to 1 in 28 and 1 in 37 people suffering and dying from lung cancer. The age-related risk of developing and dying of lung cancer varies among geographic locations with different HDIs.  \nKeywords: Risk assessment; Lung cancer; Incidence; Mortality; Global Health; GLOBOCAN; HDI  \nIntroduction  \nLung cancer is the most common cancer and leading cause of cancer deaths in the world, accounting for 12.4% of new cases and 18.7% of all cancer deaths. [1] Lung cancer has become an escalating public health and economic problem, with approximately 2.2 million lung cancer cases and 1.8 million lung cancer deaths worldwide. [1,2] Prior and present smoking has always been the most confirmable and predominant risk factor of lung cancer. [3,4] Additionally, secondhand smoke exposure is also a significant factor in lung cancer development. [5] Other risk factors, such as exposure to alternative fuels, carcinogenic substances found in various industries, and the presence of air pollutants, affect the probability of lung cancer incidence and exhibit substantial variation among  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code: | Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10.1097/CM9.0000000000003368 |\n\ndifferent nations. Furthermore, lung cancer incidence and mortality rates vary significantly across various geographical areas globally, reflecting variations in smoking habits and economic developmental trends. Lung cancer also exhibits sex-related differences. Typically, the incidence and mortality rates of lung cancer in men are approximately twice those in women, although sex differences vary globally. [2]  \nIncidence and mortality rates demonstrate the effects of ","cbCaivnuRN2sYs7P","https://ap.wps.com/l/cbCaivnuRN2sYs7P","pdf",3386939,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Lung cancer burden and risk factors\n## Population health indicators and lifetime risk concept\n# Correspondence and publication details","[{\"question\":\"What does “lifetime cancer risk” mean in this study?\",\"answer\":\"It represents the cumulative probability that a person will be diagnosed with cancer at some age during their lifetime, while considering mortality from other causes.\"},{\"question\":\"How were lifetime risks of lung cancer developing and death estimated?\",\"answer\":\"Lung cancer data came from GLOBOCAN 2022 and death data from the United Nations. The study estimated lifetime risks using the adjustment for multiple primary cancers (AMP) method.\"},{\"question\":\"What were the global lifetime risks in 2022?\",\"answer\":\"In 2022, the global lifetime risk of developing lung cancer was 3.49% and the lifetime risk of dying from lung cancer was 2.69%.\"}]","Global, regional, and national lifetime risk of developing and dying from lung cancer in 2022 - A population-based study in 185 countries | PDF",1790006253,18]